Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinzhen Oral Liquid for Mild Pediatric Viral Pneumonia (Phase II, Multicenter, Randomized, Double-blind, Multiple-dose)
CTR20231958Phase 2Active
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Oct 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Jinzhen in viral pneumonia, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Oct 2023; status: active.
02
Drugs
Jinzhen
03
Conditions
viral pneumonia
Beyond the preview
Go deeper on CTR20231958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231958.